Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with Type 2 diabetes mellitus.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Pioglitazone; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patients with Type 2 Diabetes Mellitus with inadequate glycemic control

Exclusion Criteria:

• Patients with Type 1 Diabetes Mellitus